Home › Funds › Fulcrum Capital LLC › EW

Fulcrum Capital LLC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Fulcrum Capital LLC reported holding 132,586 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 2.18% of its reported portfolio and ranking #12 among its reported holdings. Fulcrum Capital LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)132.59K sh
Reported value held$11.44M
Portfolio Weight2.18%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Fulcrum Capital LLC's EW position evolved

Fulcrum Capital LLC first disclosed a stake in EW in Q3 2023 at 93,996 shares (US$6.5M). The position peaked in Q2 2026 at 131,371 shares, worth US$11.9M. Across 13 filings, Fulcrum Capital LLC increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 132,586 shares valued at US$11.4M — an increase of 1,215 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 94.00K $6.51M New
Q4 2023 113.09K $8.62M Add
Q1 2024 113.57K $10.85M Hold
Q2 2024 113.84K $10.52M Hold
Q3 2024 117.91K $7.78M Add
Q4 2024 122.01K $9.03M Add
Q1 2025 126.27K $9.15M Add
Q2 2025 131.11K $10.25M Add
Q3 2025 133.87K $10.41M Add
Q4 2025 137.22K $11.70M Add
Q1 2026 137.34K $11.00M Hold
Q2 2026 131.37K $11.88M Reduce
Q3 2026 132.59K $11.44M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Fulcrum Capital LLC held EW?

Fulcrum Capital LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Fulcrum Capital LLC's current position in EW?

As of Q3 2026, Fulcrum Capital LLC holds 132.59K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $11.44M, representing 2.18% of its reported portfolio and ranking #12.

Has Fulcrum Capital LLC been buying or selling EW?

In the latest 13F filing (Q3 2026), Fulcrum Capital LLC increased its position in EW. The position peaked in Q2 2026 at 131.37K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.